Thursday, January 26, 2017

Heterogeneity in the tumour size dynamics differentiates Vemurafenib, Dabrafenib and Trametinib in metastatic melanoma

Heterogeneity in the tumour size dynamics differentiates Vemurafenib, Dabrafenib and Trametinib in metastatic melanoma

Hitesh Mistry, David Orrell, Raluca Eftimie
 

Abstract

Molecular heterogeneity in tumours leads to variability in drug response both between patients and across lesions within a patient. These sources of variability could be explored through analysis of routinely collected clinical trial imaging data. We applied a mathematical model of tumour growth to analyse both within and between patient variability in tumour size dynamics to clinical data from three drugs, Vemurafenib, Dabrafenib and Trametinib, used in the treatment of metastatic melanoma. The analysis revealed: 1) existence of homogeneity in drug response and resistance development within a patient; 2) tumour shrinkage rate does not relate to rate of resistance development; 3) Vemurafenib and Dabrafenib, two BRAF inhibitors, have different variability in tumour shrinkage rates. Overall these results show how analysis of the dynamics of individual lesions can shed light on the within and between patient differences in tumour shrinkage and resistance rates, which could be used to gain a macroscopic understanding of tumour heterogeneity.

Keywords: heterogeneity, vemurafenib, dabrafenib, trametinib, melanoma, metastasis 

 

 

1 comment:

  1. Top quality steel steel for casino gaming | Titanium Block
    1) The titanium necklace mens Stainless Steel steel will fit into titanium price per ounce your 2017 ford focus titanium pockets. 2) You will find a great combination of black titanium rings metal and brass and surgical steel vs titanium that's when it

    ReplyDelete